ARTICLE | Company News
Kyto Biopharma Inc., Medarex deal
December 16, 2002 8:00 AM UTC
MEDX and Kyto (formerly B. Twelve Inc.) restructured a 2001 deal to develop and market cancer therapeutics using MEDX’s UltiMAb Human Antibody Development System and Kyto’s vitamin B12 related targets...